nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—SLC6A2—Clonidine—glaucoma	0.171	0.376	CbGbCtD
Sibutramine—CYP3A4—Pilocarpine—glaucoma	0.0667	0.147	CbGbCtD
Sibutramine—CYP3A4—Brinzolamide—glaucoma	0.0523	0.115	CbGbCtD
Sibutramine—CYP3A4—Dorzolamide—glaucoma	0.0505	0.111	CbGbCtD
Sibutramine—CYP3A4—Methazolamide—glaucoma	0.045	0.0992	CbGbCtD
Sibutramine—CYP3A4—Acetazolamide—glaucoma	0.036	0.0793	CbGbCtD
Sibutramine—CYP3A4—Clonidine—glaucoma	0.0326	0.0717	CbGbCtD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00393	0.0785	CbGpPWpGaD
Sibutramine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00288	0.0576	CbGpPWpGaD
Sibutramine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00255	0.051	CbGpPWpGaD
Sibutramine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00211	0.0421	CbGpPWpGaD
Sibutramine—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.002	0.0399	CbGpPWpGaD
Sibutramine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00187	0.0373	CbGpPWpGaD
Sibutramine—SLC6A3—Amine compound SLC transporters—SLC6A13—glaucoma	0.00177	0.0354	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—ATOH7—glaucoma	0.00175	0.0349	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—SLC6A1—glaucoma	0.00162	0.0323	CbGpPWpGaD
Sibutramine—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.00146	0.0292	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.00139	0.0278	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00138	0.0276	CbGpPWpGaD
Sibutramine—SLC6A3—Amine compound SLC transporters—SLC6A1—glaucoma	0.0013	0.0259	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—SLC6A1—glaucoma	0.00123	0.0246	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000782	0.0156	CbGpPWpGaD
Sibutramine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000721	0.0144	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000705	0.0141	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—OPN4—glaucoma	0.000696	0.0139	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000693	0.0138	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC6A13—glaucoma	0.000656	0.0131	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000572	0.0114	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000564	0.0113	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TXN—glaucoma	0.000538	0.0108	CbGpPWpGaD
Sibutramine—SLC6A3—Alpha-synuclein signaling—BAD—glaucoma	0.000537	0.0107	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000533	0.0106	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000507	0.0101	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A13—glaucoma	0.0005	0.00998	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000495	0.00988	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC6A1—glaucoma	0.00048	0.00958	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000472	0.00942	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000463	0.00925	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000414	0.00827	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000413	0.00824	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TXN—glaucoma	0.00041	0.00819	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000401	0.008	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TGFB2—glaucoma	0.000391	0.00781	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000388	0.00776	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000366	0.00731	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	0.000366	0.0073	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000355	0.0071	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000355	0.00709	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000354	0.00707	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—glaucoma	0.000341	0.00681	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.000336	0.00672	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000331	0.00661	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000315	0.00629	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFB2—glaucoma	0.000298	0.00595	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC6A13—glaucoma	0.000298	0.00594	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000293	0.00585	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000284	0.00568	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000271	0.00541	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—glaucoma	0.000266	0.00531	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000264	0.00528	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00026	0.00519	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—glaucoma	0.00026	0.00519	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000254	0.00507	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000249	0.00497	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NGFR—glaucoma	0.000248	0.00495	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00024	0.00479	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	0.000236	0.00471	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000234	0.00468	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000233	0.00466	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00023	0.0046	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—glaucoma	0.000229	0.00457	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC6A1—glaucoma	0.000218	0.00435	CbGpPWpGaD
Sibutramine—Pruritus—Bimatoprost—glaucoma	0.00021	0.000423	CcSEcCtD
Sibutramine—Immune system disorder—Betaxolol—glaucoma	0.000209	0.000422	CcSEcCtD
Sibutramine—Diarrhoea—Apraclonidine—glaucoma	0.000209	0.000422	CcSEcCtD
Sibutramine—Malaise—Clonidine—glaucoma	0.000209	0.000421	CcSEcCtD
Sibutramine—Dyspepsia—Pilocarpine—glaucoma	0.000209	0.00042	CcSEcCtD
Sibutramine—Chills—Betaxolol—glaucoma	0.000208	0.000419	CcSEcCtD
Sibutramine—Syncope—Clonidine—glaucoma	0.000208	0.000419	CcSEcCtD
Sibutramine—Arrhythmia—Betaxolol—glaucoma	0.000207	0.000418	CcSEcCtD
Sibutramine—Feeling abnormal—Dorzolamide—glaucoma	0.000207	0.000417	CcSEcCtD
Sibutramine—Decreased appetite—Pilocarpine—glaucoma	0.000206	0.000415	CcSEcCtD
Sibutramine—Feeling abnormal—Travoprost—glaucoma	0.000206	0.000415	CcSEcCtD
Sibutramine—Conjunctivitis—Timolol—glaucoma	0.000205	0.000413	CcSEcCtD
Sibutramine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000205	0.000413	CcSEcCtD
Sibutramine—Alopecia—Betaxolol—glaucoma	0.000205	0.000413	CcSEcCtD
Sibutramine—Palpitations—Clonidine—glaucoma	0.000205	0.000413	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000204	0.000412	CcSEcCtD
Sibutramine—Gastrointestinal pain—Travoprost—glaucoma	0.000204	0.000412	CcSEcCtD
Sibutramine—Loss of consciousness—Clonidine—glaucoma	0.000204	0.000411	CcSEcCtD
Sibutramine—Feeling abnormal—Brinzolamide—glaucoma	0.000203	0.000409	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—glaucoma	0.000203	0.00405	CbGpPWpGaD
Sibutramine—Pain—Pilocarpine—glaucoma	0.000203	0.000408	CcSEcCtD
Sibutramine—Constipation—Pilocarpine—glaucoma	0.000203	0.000408	CcSEcCtD
Sibutramine—Cough—Clonidine—glaucoma	0.000202	0.000408	CcSEcCtD
Sibutramine—Sweating—Timolol—glaucoma	0.000202	0.000408	CcSEcCtD
Sibutramine—Dizziness—Apraclonidine—glaucoma	0.000202	0.000408	CcSEcCtD
Sibutramine—Malnutrition—Betaxolol—glaucoma	0.000202	0.000407	CcSEcCtD
Sibutramine—Urticaria—Dorzolamide—glaucoma	0.000199	0.000402	CcSEcCtD
Sibutramine—Epistaxis—Timolol—glaucoma	0.000199	0.000401	CcSEcCtD
Sibutramine—Abdominal pain—Dorzolamide—glaucoma	0.000198	0.0004	CcSEcCtD
Sibutramine—Body temperature increased—Dorzolamide—glaucoma	0.000198	0.0004	CcSEcCtD
Sibutramine—Tension—Betaxolol—glaucoma	0.000198	0.000399	CcSEcCtD
Sibutramine—Sinusitis—Timolol—glaucoma	0.000198	0.000399	CcSEcCtD
Sibutramine—Dysgeusia—Betaxolol—glaucoma	0.000198	0.000398	CcSEcCtD
Sibutramine—Chest pain—Clonidine—glaucoma	0.000197	0.000398	CcSEcCtD
Sibutramine—Arthralgia—Clonidine—glaucoma	0.000197	0.000398	CcSEcCtD
Sibutramine—Abdominal pain—Travoprost—glaucoma	0.000197	0.000398	CcSEcCtD
Sibutramine—Anxiety—Clonidine—glaucoma	0.000197	0.000396	CcSEcCtD
Sibutramine—Asthenia—Acetazolamide—glaucoma	0.000196	0.000396	CcSEcCtD
Sibutramine—Dizziness—Bimatoprost—glaucoma	0.000196	0.000395	CcSEcCtD
Sibutramine—Nervousness—Betaxolol—glaucoma	0.000196	0.000395	CcSEcCtD
Sibutramine—Urticaria—Brinzolamide—glaucoma	0.000196	0.000395	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000196	0.0039	CbGpPWpGaD
Sibutramine—Feeling abnormal—Pilocarpine—glaucoma	0.000195	0.000394	CcSEcCtD
Sibutramine—Discomfort—Clonidine—glaucoma	0.000195	0.000393	CcSEcCtD
Sibutramine—Vomiting—Apraclonidine—glaucoma	0.000194	0.000392	CcSEcCtD
Sibutramine—Muscle spasms—Betaxolol—glaucoma	0.000194	0.000391	CcSEcCtD
Sibutramine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000194	0.000391	CcSEcCtD
Sibutramine—Hypersensitivity—Brimonidine—glaucoma	0.000193	0.00039	CcSEcCtD
Sibutramine—Dry mouth—Clonidine—glaucoma	0.000193	0.000389	CcSEcCtD
Sibutramine—Bradycardia—Timolol—glaucoma	0.000193	0.000389	CcSEcCtD
Sibutramine—Dermatitis—Apraclonidine—glaucoma	0.000193	0.000388	CcSEcCtD
Sibutramine—Headache—Apraclonidine—glaucoma	0.000192	0.000386	CcSEcCtD
Sibutramine—Confusional state—Clonidine—glaucoma	0.000191	0.000385	CcSEcCtD
Sibutramine—Vision blurred—Betaxolol—glaucoma	0.00019	0.000383	CcSEcCtD
Sibutramine—Rhinitis—Timolol—glaucoma	0.00019	0.000383	CcSEcCtD
Sibutramine—Oedema—Clonidine—glaucoma	0.000189	0.000381	CcSEcCtD
Sibutramine—Tremor—Betaxolol—glaucoma	0.000189	0.000381	CcSEcCtD
Sibutramine—Asthenia—Brimonidine—glaucoma	0.000188	0.00038	CcSEcCtD
Sibutramine—Infection—Clonidine—glaucoma	0.000188	0.000379	CcSEcCtD
Sibutramine—Body temperature increased—Pilocarpine—glaucoma	0.000187	0.000378	CcSEcCtD
Sibutramine—Abdominal pain—Pilocarpine—glaucoma	0.000187	0.000378	CcSEcCtD
Sibutramine—Ill-defined disorder—Betaxolol—glaucoma	0.000187	0.000378	CcSEcCtD
Sibutramine—Diarrhoea—Acetazolamide—glaucoma	0.000187	0.000377	CcSEcCtD
Sibutramine—Rash—Bimatoprost—glaucoma	0.000187	0.000377	CcSEcCtD
Sibutramine—Dermatitis—Bimatoprost—glaucoma	0.000187	0.000377	CcSEcCtD
Sibutramine—Oedema peripheral—Timolol—glaucoma	0.000187	0.000376	CcSEcCtD
Sibutramine—Anaemia—Betaxolol—glaucoma	0.000187	0.000376	CcSEcCtD
Sibutramine—Shock—Clonidine—glaucoma	0.000186	0.000375	CcSEcCtD
Sibutramine—Pruritus—Brimonidine—glaucoma	0.000186	0.000374	CcSEcCtD
Sibutramine—Headache—Bimatoprost—glaucoma	0.000186	0.000374	CcSEcCtD
Sibutramine—Thrombocytopenia—Clonidine—glaucoma	0.000185	0.000373	CcSEcCtD
Sibutramine—Hypersensitivity—Dorzolamide—glaucoma	0.000185	0.000372	CcSEcCtD
Sibutramine—Tachycardia—Clonidine—glaucoma	0.000185	0.000372	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—FAS—glaucoma	0.000185	0.00369	CbGpPWpGaD
Sibutramine—Hypersensitivity—Travoprost—glaucoma	0.000184	0.000371	CcSEcCtD
Sibutramine—Skin disorder—Clonidine—glaucoma	0.000184	0.00037	CcSEcCtD
Sibutramine—Hyperhidrosis—Clonidine—glaucoma	0.000183	0.000369	CcSEcCtD
Sibutramine—Visual impairment—Timolol—glaucoma	0.000182	0.000368	CcSEcCtD
Sibutramine—Malaise—Betaxolol—glaucoma	0.000182	0.000367	CcSEcCtD
Sibutramine—Nausea—Apraclonidine—glaucoma	0.000182	0.000366	CcSEcCtD
Sibutramine—Hypersensitivity—Brinzolamide—glaucoma	0.000182	0.000366	CcSEcCtD
Sibutramine—Vertigo—Betaxolol—glaucoma	0.000181	0.000366	CcSEcCtD
Sibutramine—Syncope—Betaxolol—glaucoma	0.000181	0.000365	CcSEcCtD
Sibutramine—Dizziness—Acetazolamide—glaucoma	0.000181	0.000365	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000181	0.00361	CbGpPWpGaD
Sibutramine—Anorexia—Clonidine—glaucoma	0.00018	0.000364	CcSEcCtD
Sibutramine—Asthenia—Dorzolamide—glaucoma	0.00018	0.000363	CcSEcCtD
Sibutramine—Asthenia—Travoprost—glaucoma	0.000179	0.000361	CcSEcCtD
Sibutramine—Palpitations—Betaxolol—glaucoma	0.000178	0.00036	CcSEcCtD
Sibutramine—Pruritus—Dorzolamide—glaucoma	0.000177	0.000358	CcSEcCtD
Sibutramine—Loss of consciousness—Betaxolol—glaucoma	0.000177	0.000358	CcSEcCtD
Sibutramine—Eye disorder—Timolol—glaucoma	0.000177	0.000357	CcSEcCtD
Sibutramine—Asthenia—Brinzolamide—glaucoma	0.000177	0.000357	CcSEcCtD
Sibutramine—Hypotension—Clonidine—glaucoma	0.000177	0.000356	CcSEcCtD
Sibutramine—Pruritus—Travoprost—glaucoma	0.000177	0.000356	CcSEcCtD
Sibutramine—Tinnitus—Timolol—glaucoma	0.000177	0.000356	CcSEcCtD
Sibutramine—Cough—Betaxolol—glaucoma	0.000176	0.000355	CcSEcCtD
Sibutramine—Nausea—Bimatoprost—glaucoma	0.000176	0.000355	CcSEcCtD
Sibutramine—Hypersensitivity—Pilocarpine—glaucoma	0.000175	0.000352	CcSEcCtD
Sibutramine—Pruritus—Brinzolamide—glaucoma	0.000174	0.000352	CcSEcCtD
Sibutramine—Vomiting—Acetazolamide—glaucoma	0.000174	0.000351	CcSEcCtD
Sibutramine—Dizziness—Brimonidine—glaucoma	0.000174	0.00035	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000172	0.000347	CcSEcCtD
Sibutramine—Angiopathy—Timolol—glaucoma	0.000172	0.000346	CcSEcCtD
Sibutramine—Arthralgia—Betaxolol—glaucoma	0.000172	0.000346	CcSEcCtD
Sibutramine—Chest pain—Betaxolol—glaucoma	0.000172	0.000346	CcSEcCtD
Sibutramine—Myalgia—Betaxolol—glaucoma	0.000172	0.000346	CcSEcCtD
Sibutramine—Diarrhoea—Dorzolamide—glaucoma	0.000172	0.000346	CcSEcCtD
Sibutramine—Headache—Acetazolamide—glaucoma	0.000171	0.000345	CcSEcCtD
Sibutramine—Anxiety—Betaxolol—glaucoma	0.000171	0.000345	CcSEcCtD
Sibutramine—Insomnia—Clonidine—glaucoma	0.000171	0.000345	CcSEcCtD
Sibutramine—Immune system disorder—Timolol—glaucoma	0.000171	0.000345	CcSEcCtD
Sibutramine—Diarrhoea—Travoprost—glaucoma	0.000171	0.000344	CcSEcCtD
Sibutramine—Asthenia—Pilocarpine—glaucoma	0.00017	0.000343	CcSEcCtD
Sibutramine—Paraesthesia—Clonidine—glaucoma	0.00017	0.000342	CcSEcCtD
Sibutramine—Discomfort—Betaxolol—glaucoma	0.00017	0.000342	CcSEcCtD
Sibutramine—Arrhythmia—Timolol—glaucoma	0.000169	0.000341	CcSEcCtD
Sibutramine—Dyspnoea—Clonidine—glaucoma	0.000169	0.00034	CcSEcCtD
Sibutramine—Diarrhoea—Brinzolamide—glaucoma	0.000169	0.00034	CcSEcCtD
Sibutramine—Somnolence—Clonidine—glaucoma	0.000168	0.000339	CcSEcCtD
Sibutramine—Dry mouth—Betaxolol—glaucoma	0.000168	0.000339	CcSEcCtD
Sibutramine—Pruritus—Pilocarpine—glaucoma	0.000168	0.000338	CcSEcCtD
Sibutramine—Alopecia—Timolol—glaucoma	0.000167	0.000337	CcSEcCtD
Sibutramine—Confusional state—Betaxolol—glaucoma	0.000166	0.000335	CcSEcCtD
Sibutramine—Dizziness—Dorzolamide—glaucoma	0.000166	0.000334	CcSEcCtD
Sibutramine—Rash—Brimonidine—glaucoma	0.000166	0.000334	CcSEcCtD
Sibutramine—Dermatitis—Brimonidine—glaucoma	0.000165	0.000333	CcSEcCtD
Sibutramine—Dizziness—Travoprost—glaucoma	0.000165	0.000333	CcSEcCtD
Sibutramine—Malnutrition—Timolol—glaucoma	0.000165	0.000332	CcSEcCtD
Sibutramine—Oedema—Betaxolol—glaucoma	0.000165	0.000332	CcSEcCtD
Sibutramine—Headache—Brimonidine—glaucoma	0.000164	0.000332	CcSEcCtD
Sibutramine—Decreased appetite—Clonidine—glaucoma	0.000164	0.000332	CcSEcCtD
Sibutramine—Infection—Betaxolol—glaucoma	0.000164	0.00033	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Clonidine—glaucoma	0.000163	0.000329	CcSEcCtD
Sibutramine—Dizziness—Brinzolamide—glaucoma	0.000163	0.000329	CcSEcCtD
Sibutramine—Nausea—Acetazolamide—glaucoma	0.000162	0.000328	CcSEcCtD
Sibutramine—Diarrhoea—Pilocarpine—glaucoma	0.000162	0.000327	CcSEcCtD
Sibutramine—Shock—Betaxolol—glaucoma	0.000162	0.000327	CcSEcCtD
Sibutramine—Tension—Timolol—glaucoma	0.000162	0.000326	CcSEcCtD
Sibutramine—Pain—Clonidine—glaucoma	0.000162	0.000326	CcSEcCtD
Sibutramine—Constipation—Clonidine—glaucoma	0.000162	0.000326	CcSEcCtD
Sibutramine—Dysgeusia—Timolol—glaucoma	0.000161	0.000325	CcSEcCtD
Sibutramine—Thrombocytopenia—Betaxolol—glaucoma	0.000161	0.000325	CcSEcCtD
Sibutramine—Tachycardia—Betaxolol—glaucoma	0.000161	0.000324	CcSEcCtD
Sibutramine—Nervousness—Timolol—glaucoma	0.00016	0.000323	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00016	0.00319	CbGpPWpGaD
Sibutramine—Skin disorder—Betaxolol—glaucoma	0.00016	0.000323	CcSEcCtD
Sibutramine—Vomiting—Dorzolamide—glaucoma	0.000159	0.000321	CcSEcCtD
Sibutramine—Hyperhidrosis—Betaxolol—glaucoma	0.000159	0.000321	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000158	0.00316	CbGpPWpGaD
Sibutramine—Rash—Dorzolamide—glaucoma	0.000158	0.000319	CcSEcCtD
Sibutramine—Dermatitis—Dorzolamide—glaucoma	0.000158	0.000318	CcSEcCtD
Sibutramine—Rash—Travoprost—glaucoma	0.000157	0.000317	CcSEcCtD
Sibutramine—Dermatitis—Travoprost—glaucoma	0.000157	0.000317	CcSEcCtD
Sibutramine—Headache—Dorzolamide—glaucoma	0.000157	0.000317	CcSEcCtD
Sibutramine—Anorexia—Betaxolol—glaucoma	0.000157	0.000317	CcSEcCtD
Sibutramine—Vomiting—Brinzolamide—glaucoma	0.000157	0.000316	CcSEcCtD
Sibutramine—Dizziness—Pilocarpine—glaucoma	0.000157	0.000316	CcSEcCtD
Sibutramine—Headache—Travoprost—glaucoma	0.000156	0.000315	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000156	0.00312	CbGpPWpGaD
Sibutramine—Nausea—Brimonidine—glaucoma	0.000156	0.000314	CcSEcCtD
Sibutramine—Feeling abnormal—Clonidine—glaucoma	0.000156	0.000314	CcSEcCtD
Sibutramine—Rash—Brinzolamide—glaucoma	0.000155	0.000313	CcSEcCtD
Sibutramine—Vision blurred—Timolol—glaucoma	0.000155	0.000313	CcSEcCtD
Sibutramine—Dermatitis—Brinzolamide—glaucoma	0.000155	0.000313	CcSEcCtD
Sibutramine—Gastrointestinal pain—Clonidine—glaucoma	0.000155	0.000312	CcSEcCtD
Sibutramine—Headache—Brinzolamide—glaucoma	0.000154	0.000311	CcSEcCtD
Sibutramine—Hypotension—Betaxolol—glaucoma	0.000154	0.00031	CcSEcCtD
Sibutramine—Angioedema—Timolol—glaucoma	0.000151	0.000304	CcSEcCtD
Sibutramine—Vomiting—Pilocarpine—glaucoma	0.000151	0.000304	CcSEcCtD
Sibutramine—Urticaria—Clonidine—glaucoma	0.00015	0.000303	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00015	0.000303	CcSEcCtD
Sibutramine—Abdominal pain—Clonidine—glaucoma	0.00015	0.000302	CcSEcCtD
Sibutramine—Body temperature increased—Clonidine—glaucoma	0.00015	0.000302	CcSEcCtD
Sibutramine—Rash—Pilocarpine—glaucoma	0.000149	0.000301	CcSEcCtD
Sibutramine—Dermatitis—Pilocarpine—glaucoma	0.000149	0.000301	CcSEcCtD
Sibutramine—Insomnia—Betaxolol—glaucoma	0.000149	0.0003	CcSEcCtD
Sibutramine—Nausea—Dorzolamide—glaucoma	0.000149	0.0003	CcSEcCtD
Sibutramine—Headache—Pilocarpine—glaucoma	0.000148	0.000299	CcSEcCtD
Sibutramine—Nausea—Travoprost—glaucoma	0.000148	0.000299	CcSEcCtD
Sibutramine—Vertigo—Timolol—glaucoma	0.000148	0.000299	CcSEcCtD
Sibutramine—Paraesthesia—Betaxolol—glaucoma	0.000148	0.000298	CcSEcCtD
Sibutramine—Syncope—Timolol—glaucoma	0.000148	0.000298	CcSEcCtD
Sibutramine—Dyspnoea—Betaxolol—glaucoma	0.000147	0.000296	CcSEcCtD
Sibutramine—Nausea—Brinzolamide—glaucoma	0.000146	0.000295	CcSEcCtD
Sibutramine—Palpitations—Timolol—glaucoma	0.000146	0.000294	CcSEcCtD
Sibutramine—Dyspepsia—Betaxolol—glaucoma	0.000145	0.000292	CcSEcCtD
Sibutramine—Loss of consciousness—Timolol—glaucoma	0.000145	0.000292	CcSEcCtD
Sibutramine—Cough—Timolol—glaucoma	0.000144	0.00029	CcSEcCtD
Sibutramine—Decreased appetite—Betaxolol—glaucoma	0.000143	0.000289	CcSEcCtD
Sibutramine—Hypertension—Timolol—glaucoma	0.000142	0.000287	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000142	0.000287	CcSEcCtD
Sibutramine—Pain—Betaxolol—glaucoma	0.000141	0.000284	CcSEcCtD
Sibutramine—Constipation—Betaxolol—glaucoma	0.000141	0.000284	CcSEcCtD
Sibutramine—Nausea—Pilocarpine—glaucoma	0.000141	0.000284	CcSEcCtD
Sibutramine—Chest pain—Timolol—glaucoma	0.00014	0.000283	CcSEcCtD
Sibutramine—Arthralgia—Timolol—glaucoma	0.00014	0.000283	CcSEcCtD
Sibutramine—Myalgia—Timolol—glaucoma	0.00014	0.000283	CcSEcCtD
Sibutramine—Anxiety—Timolol—glaucoma	0.00014	0.000282	CcSEcCtD
Sibutramine—Hypersensitivity—Clonidine—glaucoma	0.000139	0.000281	CcSEcCtD
Sibutramine—Discomfort—Timolol—glaucoma	0.000139	0.00028	CcSEcCtD
Sibutramine—Dry mouth—Timolol—glaucoma	0.000137	0.000277	CcSEcCtD
Sibutramine—Asthenia—Clonidine—glaucoma	0.000136	0.000274	CcSEcCtD
Sibutramine—Feeling abnormal—Betaxolol—glaucoma	0.000136	0.000274	CcSEcCtD
Sibutramine—Confusional state—Timolol—glaucoma	0.000136	0.000274	CcSEcCtD
Sibutramine—Anaphylactic shock—Timolol—glaucoma	0.000135	0.000271	CcSEcCtD
Sibutramine—Oedema—Timolol—glaucoma	0.000135	0.000271	CcSEcCtD
Sibutramine—Pruritus—Clonidine—glaucoma	0.000134	0.00027	CcSEcCtD
Sibutramine—Infection—Timolol—glaucoma	0.000134	0.000269	CcSEcCtD
Sibutramine—Shock—Timolol—glaucoma	0.000132	0.000267	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000132	0.00264	CbGpPWpGaD
Sibutramine—Urticaria—Betaxolol—glaucoma	0.000131	0.000264	CcSEcCtD
Sibutramine—Skin disorder—Timolol—glaucoma	0.000131	0.000263	CcSEcCtD
Sibutramine—Body temperature increased—Betaxolol—glaucoma	0.00013	0.000262	CcSEcCtD
Sibutramine—Hyperhidrosis—Timolol—glaucoma	0.00013	0.000262	CcSEcCtD
Sibutramine—Diarrhoea—Clonidine—glaucoma	0.000129	0.000261	CcSEcCtD
Sibutramine—Anorexia—Timolol—glaucoma	0.000128	0.000259	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000128	0.00256	CbGpPWpGaD
Sibutramine—Hypotension—Timolol—glaucoma	0.000126	0.000253	CcSEcCtD
Sibutramine—Dizziness—Clonidine—glaucoma	0.000125	0.000252	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Timolol—glaucoma	0.000123	0.000247	CcSEcCtD
Sibutramine—Insomnia—Timolol—glaucoma	0.000122	0.000245	CcSEcCtD
Sibutramine—Hypersensitivity—Betaxolol—glaucoma	0.000121	0.000245	CcSEcCtD
Sibutramine—Paraesthesia—Timolol—glaucoma	0.000121	0.000244	CcSEcCtD
Sibutramine—Vomiting—Clonidine—glaucoma	0.00012	0.000243	CcSEcCtD
Sibutramine—Dyspnoea—Timolol—glaucoma	0.00012	0.000242	CcSEcCtD
Sibutramine—Somnolence—Timolol—glaucoma	0.00012	0.000241	CcSEcCtD
Sibutramine—Rash—Clonidine—glaucoma	0.000119	0.00024	CcSEcCtD
Sibutramine—Dermatitis—Clonidine—glaucoma	0.000119	0.00024	CcSEcCtD
Sibutramine—Headache—Clonidine—glaucoma	0.000119	0.000239	CcSEcCtD
Sibutramine—Dyspepsia—Timolol—glaucoma	0.000118	0.000239	CcSEcCtD
Sibutramine—Asthenia—Betaxolol—glaucoma	0.000118	0.000238	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000117	0.00234	CbGpPWpGaD
Sibutramine—Decreased appetite—Timolol—glaucoma	0.000117	0.000236	CcSEcCtD
Sibutramine—Pruritus—Betaxolol—glaucoma	0.000117	0.000235	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Timolol—glaucoma	0.000116	0.000234	CcSEcCtD
Sibutramine—Pain—Timolol—glaucoma	0.000115	0.000232	CcSEcCtD
Sibutramine—Diarrhoea—Betaxolol—glaucoma	0.000113	0.000227	CcSEcCtD
Sibutramine—Nausea—Clonidine—glaucoma	0.000112	0.000227	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000112	0.00224	CbGpPWpGaD
Sibutramine—Feeling abnormal—Timolol—glaucoma	0.000111	0.000224	CcSEcCtD
Sibutramine—Gastrointestinal pain—Timolol—glaucoma	0.00011	0.000222	CcSEcCtD
Sibutramine—Dizziness—Betaxolol—glaucoma	0.000109	0.00022	CcSEcCtD
Sibutramine—Urticaria—Timolol—glaucoma	0.000107	0.000216	CcSEcCtD
Sibutramine—Body temperature increased—Timolol—glaucoma	0.000106	0.000214	CcSEcCtD
Sibutramine—Abdominal pain—Timolol—glaucoma	0.000106	0.000214	CcSEcCtD
Sibutramine—Vomiting—Betaxolol—glaucoma	0.000105	0.000211	CcSEcCtD
Sibutramine—Rash—Betaxolol—glaucoma	0.000104	0.000209	CcSEcCtD
Sibutramine—Dermatitis—Betaxolol—glaucoma	0.000104	0.000209	CcSEcCtD
Sibutramine—Headache—Betaxolol—glaucoma	0.000103	0.000208	CcSEcCtD
Sibutramine—Hypersensitivity—Timolol—glaucoma	9.91e-05	0.0002	CcSEcCtD
Sibutramine—Nausea—Betaxolol—glaucoma	9.78e-05	0.000197	CcSEcCtD
Sibutramine—Asthenia—Timolol—glaucoma	9.65e-05	0.000195	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	9.6e-05	0.00192	CbGpPWpGaD
Sibutramine—Pruritus—Timolol—glaucoma	9.52e-05	0.000192	CcSEcCtD
Sibutramine—Diarrhoea—Timolol—glaucoma	9.21e-05	0.000186	CcSEcCtD
Sibutramine—Dizziness—Timolol—glaucoma	8.9e-05	0.000179	CcSEcCtD
Sibutramine—Vomiting—Timolol—glaucoma	8.55e-05	0.000172	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—glaucoma	8.54e-05	0.00171	CbGpPWpGaD
Sibutramine—Rash—Timolol—glaucoma	8.48e-05	0.000171	CcSEcCtD
Sibutramine—Dermatitis—Timolol—glaucoma	8.47e-05	0.000171	CcSEcCtD
Sibutramine—Headache—Timolol—glaucoma	8.43e-05	0.00017	CcSEcCtD
Sibutramine—Nausea—Timolol—glaucoma	7.99e-05	0.000161	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—glaucoma	6.91e-05	0.00138	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.81e-05	0.00136	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.71e-05	0.00134	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA5A—glaucoma	5.99e-05	0.0012	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NARFL—glaucoma	5.99e-05	0.0012	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.44e-05	0.00109	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.37e-05	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA1—glaucoma	2.92e-05	0.000584	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CTSA—glaucoma	2.83e-05	0.000566	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA2—glaucoma	2.67e-05	0.000534	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TXN—glaucoma	1.88e-05	0.000376	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—glaucoma	1.46e-05	0.000292	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCA1—glaucoma	1.16e-05	0.000232	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.16e-05	0.000232	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—glaucoma	9.31e-06	0.000186	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—glaucoma	8.23e-06	0.000164	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOE—glaucoma	7.66e-06	0.000153	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAV1—glaucoma	7.59e-06	0.000152	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—glaucoma	5.74e-06	0.000115	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—glaucoma	5.25e-06	0.000105	CbGpPWpGaD
